(Press-News.org) UK scientists hope that lymphoma patients could benefit from a new drug that triggers the cancer-fighting properties of the body's own immune system, after highly promising early laboratory results.
The University of Manchester researchers, who were funded by the charity Leukaemia & Lymphoma Research, have shown that, when used in conjunction with radiotherapy, the new drug is potentially four times more likely to lead to long-term survival than radiotherapy alone.
Relapse is a common fate for many lymphoma patients and new treatments are desperately needed. The new research, which is published online in Blood, the Journal of the American Society of Hematology (ASH), shows that the chemical R848 can be used to prime the immune system to fight cancer.
R848 is a chemical which signals to certain molecules known as receptors found on the surface of immune cells, triggering them into action. Receptors play a key role in the function of the immune cell by recognising harmful agents and instructing the cell to respond. It was shown that injections of R848 can generate a rapid expansion of specific anti-lymphoma immune cells known as 'killer T cells'.
Dr Simon Dovedi, of the University of Manchester's School of Cancer and Enabling Sciences, who led the research, said: "Excitingly we think that R848 could be capable of giving patients a protective immunological memory by generating lymphoma-specific anti-tumour cells. This could be the key to ensuring long-term survival."
The Manchester team tested injections of R848, in combination with radiotherapy, in the laboratory on mice with lymphoma. It was found to have few side effects, with 100% of mice achieving long-term survival compared to just 28% of those mice which were treated with radiotherapy alone. In those mice that achieved long-term survival through treatment with R848 and radiotherapy, any re-introduction of cancer was completely rejected by the immune system in 75% of cases. These successful laboratory results mean that it could soon be used in early phase clinical trials for patients with lymphoma.
Professor Chris Bunce, Research Director of Leukaemia & Lymphoma Research, said: "While it is still early and this treatment has not yet been tested in humans, these results are hugely promising. One of the major obstacles to long-term successful treatment for many types of lymphoma has been relapse after initial successful treatment. Treatment with R848 can prime T cells to recognise various tumour-associated antigens, protecting patients from the return of the cancer."
###
For further information contact:
Henry Winter
Leukaemia & Lymphoma Research Press Office
44 20 7269 9019
press mobile 44 7824 375880
email: hwinter@beatingbloodcancers.org.uk
Notes to editors:
The report is published online in the journal Blood, the Journal of the American Society of Hematology (ASH), under the title 'Systemic delivery of a TLR7 agonist in combination with radiation primes durable anti-tumor immune responses in mouse models of lymphoma'. Principal authors: Dr Simon Dovedi, Dr Jamie Honeychurch and Professor Tim Illidge of The School of Cancer and Enabling Sciences, University of Manchester
Leukaemia & Lymphoma Research is dedicated to saving the lives of blood cancer patients through the promotion and assistance of research into causes, diagnosis and treatment. We are committed to advancing the interests of patients and increasing public understanding of blood cancers.
Around 30,000 people of all ages, from children and teenagers to adults are diagnosed with blood cancers like leukaemia, lymphoma and myeloma in the UK every year.
We receive no government funding and rely entirely on voluntary support. In the next five years we need to raise £120 million to continue our lifesaving work. Further information, including patient information booklets, is available from http://www.llresearch.org.uk/ beatingbloodcancers.org.uk or on 020 7405 0101.
Scientists harness immune system to prevent lymphoma relapse
2012-10-18
ELSE PRESS RELEASES FROM THIS DATE:
Genes and immune system shaped by childhood poverty, stress
2012-10-18
A University of British Columbia and Centre for Molecular Medicine and Therapeutics (CMMT) study has revealed that childhood poverty, stress as an adult, and demographics such as age, sex and ethnicity, all leave an imprint on a person's genes. And, that this imprint could play a role in our immune response.
The study was published last week in a special volume of the Proceedings of the National Academy of Sciences that looks at how experiences beginning before birth and in the years after can affect the course of a person's life.
Known as epigenetics, or the study ...
Female Pulitzer Prize winners require higher qualifications, MU study finds
2012-10-18
COLUMBIA, Mo. —The Pulitzer Prize in Journalism is one of the world's most prestigious awards. Despite progress in the last few decades, gender disparities in the field of journalism have existed as long as the profession has. Now, a University of Missouri researcher has found that female Pulitzer Prize winners are more likely to have greater qualifications than their male counterparts in order to win the coveted award.
In a study to be published in Journalism and Mass Communication Quarterly, Yong Volz, an assistant professor of journalism studies in the MU School of ...
College students and credit card debt -- parents at fault?
2012-10-18
Parents need to be good role models to help their children make sensible financial decisions, according to Adam Hancock and his team, from East Carolina University in the US. Their work highlights that parents who argue about finances contribute to increasing credit card debt among their children during their student years. Their work is published online in Springer's Journal of Family and Economic Issues.
Credit card debt among college students has been a growing concern for researchers and policymakers over the last decade. In addition, there is growing concern among ...
A cancer diagnosis does not make young people religious
2012-10-18
A sociologist of religion from the University of Copenhagen has interviewed 21 young patients diagnosed with a life-threatening cancer about their religious beliefs. She concludes that a cancer diagnosis will not make young people, who are not religious already, turn to religion. But it can confirm already existing beliefs.
"My research shows that young cancer patients' views on existential issues show consistency before and after the diagnosis: Their faith and their religious practices remain the same. However, the beliefs they already had can be confirmed and strengthened ...
How flick knife thumbs help Japan's rare fighting frogs
2012-10-18
Combat-ready spikes which shoot from fingers sounds like the weaponry of a comic book hero, but a Japanese scientist has found exactly this in a rare breed of frog. The discovery, which is published in the Journal of Zoology, reveals how the Otton frog uses spikes which protrude from a false thumb for both combat and mating.
The study, conducted by Dr Noriko Iwai from the University of Tokyo, focused on the Otton frog (Babina subaspera), whose habitat is the Amami islands of Southern Japan. Unlike most other frogs the Otton has an extra digit-like structure, a trait it ...
Ozone affects forest watersheds
2012-10-18
U.S. Forest Service and Oak Ridge National Laboratory (ORNL) scientists have found that rising levels of ozone, a greenhouse gas, may amplify the impacts of higher temperatures and reduce streamflow from forests to rivers, streams, and other water bodies. Such effects could potentially reduce water supplies available to support forest ecosystems and people in the southeastern United States.
Impacts of ozone, a global scale pollutant, on forests are not well understood at a large scale. This modeling study indicates that current and projected increases in ozone in the ...
Ongoing disparities in breastfeeding highlighted at Fourth Annual Summit on Breastfeeding
2012-10-18
New Rochelle, NY, October 18, 2012—Despite efforts to reduce disparities in breastfeeding, only 44% of African-American women report that they breastfeed compared with 66 and 68% of Hispanic and white women, respectively. According to UNICEF, there is a 14-fold difference in survival rates in the first 6 months, in developing countries, between children who have been breastfed exclusively and non-breastfed children. These disparities in breastfeeding and other key challenges and opportunities in the ongoing mission to encourage and support breastfeeding are discussed in ...
New tools for assessing the patient's experience with health care--progress report
2012-10-18
Philadelphia, Pa. (October 18, 2012) - An ongoing program is developing new tools for assessing health care quality from the most important viewpoint—that of the patient receiving care, according to a special supplement to Medical Care. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
The special issue presents a progress report on the Consumer Assessment of Healthcare Providers and Systems (CAHPS®) surveys —an Agency for Healthcare Research and Quality (AHRQ) initiative to capture patients' perspectives on healthcare. The ...
A*Star scientists identify mutation that causes skin hyperproliferation
2012-10-18
1. Scientists have identified a mutation in a gene that causes patches of very thick skin to appear on the palms and soles of affected people. This skin disorder is related, albeit in a much milder form, to that of the Indonesian 'Tree Man', Dede Koswara . These thick rough skin patches on hands and feet steadily increase in number as a person ages and often coalesce to form larger lesions. In severe cases, these lesions can be painful and debilitating.
2. The team of scientists from A*STAR's Institute of Medical Biology (IMB), in collaboration with hospitals and research ...
Developed a technology that predicts metastasis in breast cancer
2012-10-18
Researchers at the Bellvitge Biomedical Research Institute (IDIBELL) and The Institute of Photonic Sciences (ICFO) have collaborated on the development of a diagnostic tool that identifies the metastatic ability of breast cancer cells. The analysis is based on the characterization of the lipid component of the cells, which is indicative of malignancy. This has allowed the researchers to develop a classifier to discriminate cells capable of inducing metastasis. The results of the study have been published in the online version of the scientific journal PLoS ONE.
The characterization ...